{3 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 3 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 125 MG, 3-Dose Supply]
RxNorm concept 2739558, branded pack (bpck). Prescribable name: Lifyorli 125 MG, 3-Dose Pack.
- RxCUI
- 2739558
- Term type
- Branded pack (BPCK)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2739558 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- relacorilant 100 MG Oral Capsule [Lifyorli] (SBD, contains)
- relacorilant 25 MG Oral Capsule [Lifyorli] (SBD, contains)
- Pack (DF, has dose form)
- {3 (relacorilant 100 MG Oral Capsule) / 3 (relacorilant 25 MG Oral Capsule) } Pack (GPCK, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2739558 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2739558 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2739558. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.